Increasing Prevalence of Disease: Rising incidence of prostate cancer globally is a key driver contributing to growth of castrate resistant prostate cancer market.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |